OTLK icon

Outlook Therapeutics

75 hedge funds and large institutions have $29.6M invested in Outlook Therapeutics in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.59M
2 +$205K
3 +$119K
4
Goldman Sachs
Goldman Sachs
New York
+$100K
5
Bank of America
Bank of America
North Carolina
+$59.8K

Top Sellers

1 -$163K
2 -$159K
3 -$130K
4
Renaissance Technologies
Renaissance Technologies
New York
-$61K
5
GL
Graypoint LLC
New York
-$46K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$58.3K
27
$55.3K
28
$54.2K
29
$53.7K
30
$52.2K
31
$51.1K
32
$50.8K
33
$47.4K
34
$44.5K
35
$42.8K
36
$40K
37
$38.8K
38
$34K
39
$31.3K
40
$29.8K
41
$24.8K
42
$24.1K
43
$23.2K
44
$21.6K
45
$21K
46
$19.6K
47
$19.2K
48
$19K
49
$19K
50
$18.7K